BridgeMD
New treatment option for Colon Cancer
Official title A Clinico-biological Database in Cachexia in Patients With Colon Cancer
ClinicalTrials.gov ID: NCT05257135
What this study is testing
What is Biological collection?
Biological collection is an investigational medicine, being studied as a potential treatment for colon cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Creation of a prospective clinico-biological database dedicated to cachexia and undernutrition in order to carry out future research projects, to improve our knowledge of colon cancer and cachexia and to optimize the therapeutic management of patients
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years old,
- Patient treated at the Montpellier Regional Cancer Institute for colon cancer not eligible for surgery (of the primary tumor or associated...
- Patient requiring treatment for colon cancer (chemotherapy, targeted therapy, etc.),
- Patient having accepted the constraints of the research and the blood samples planned for the research
- Patient affiliated to Social Protection system
You likely can't join if
- Patient requiring surgery (for treatment of colon cancer or metastasis)
- Patient with exclusive peritoneal carcinomatosis
- Patient requiring radiotherapy
- Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
- Pregnant and/ or breastfeeding women
- Patient cared for an emergency context
See the full eligibility criteria
- Age ≥ 18 years old,
- Patient treated at the Montpellier Regional Cancer Institute for colon cancer not eligible for surgery (of the primary tumor or associated metastases), whether undergoing treatment or not,
- Patient requiring treatment for colon cancer (chemotherapy, targeted therapy, etc.),
- Patient having accepted the constraints of the research and the blood samples planned for the research
- Patient affiliated to Social Protection system
- Informed consent form signed
- Patient requiring surgery (for treatment of colon cancer or metastasis)
- Patient with exclusive peritoneal carcinomatosis
- Patient requiring radiotherapy
- Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
- Pregnant and/ or breastfeeding women
- Patient cared for an emergency context
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.